JZP-441
Product
JAZZ PHARMACEUTICALS INC.
Total Payments
$508,375
Transactions
28
Doctors
6
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $508,375 | 28 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $508,375 | 28 | 100.0% |
Top Doctors Receiving Payments for JZP-441
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pulmonary Disease | Stanford, CA | $306,200 | 8 |
| , M.D., PH.D., M.B.A | Neurology | Jackson, MS | $138,300 | 8 |
| , MD | Ophthalmology | Palo Alto, CA | $23,200 | 4 |
| , MD | Nephrology | Baltimore, MD | $18,750 | 3 |
| , MD | Cardiovascular Disease | San Francisco, CA | $17,875 | 4 |
| , MD | Hypertension Specialist | Farmington, CT | $4,050 | 1 |
Ad
Manufacturing Companies
- JAZZ PHARMACEUTICALS INC. $324,075
- Jazz Pharmaceuticals Inc. $184,300
Product Information
- Type Product
- Total Payments $508,375
- Total Doctors 6
- Transactions 28
About JZP-441
JZP-441 is a product associated with $508,375 in payments to 6 healthcare providers, recorded across 28 transactions in the CMS Open Payments database. The primary manufacturer is JAZZ PHARMACEUTICALS INC..
Payment data is available from 2023 to 2023. In 2023, $508,375 was paid across 28 transactions to 6 doctors.
The most common payment nature for JZP-441 is "Consulting Fee" ($508,375, 100.0% of total).